Please use this identifier to cite or link to this item: https://doi.org/10.1186/2047-2994-3-35
DC FieldValue
dc.titleElizabethkingia Meningoseptica Engodenous Endophthalmitis - A case report
dc.contributor.authorYoung, S.M
dc.contributor.authorLingam, G
dc.contributor.authorTambyah, P.A
dc.date.accessioned2020-10-26T08:33:34Z
dc.date.available2020-10-26T08:33:34Z
dc.date.issued2014
dc.identifier.citationYoung, S.M, Lingam, G, Tambyah, P.A (2014). Elizabethkingia Meningoseptica Engodenous Endophthalmitis - A case report. Antimicrobial Resistance and Infection Control 3 (1) : 35. ScholarBank@NUS Repository. https://doi.org/10.1186/2047-2994-3-35
dc.identifier.issn20472994
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/180374
dc.description.abstractElizabethkingia meningoseptica is a nosocomial non-fermenting gram-negative bacillus that has an increasing prevalence in health care settings, especially in intensive care environments. While it has long been recognized as a rare but serious cause of neonatal meningitis and sepsis, its role as a cause of ocular pathology is not well-known. We report the first case of E. meningoseptica endogenous endophthalmitis caused by bacteraemia by the same organism. In view of its aggressiveness and virulence in the eye, and the high rate of misdiagnosis or missed diagnosis of endogenous endophthalmitis especially given its low incidence, we may wish to consider screening all cases of E. menigoseptica bloodstream infections for endophthalmitis in future, similar to how it has become routine to refer all patients with Klebsiella bacteraemia to ophthalmologists for screening for endophthalmitis in our local hospitals. © 2014 Young et al.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectamikacin
dc.subjectcefazolin
dc.subjectciprofloxacin
dc.subjectclindamycin
dc.subjectcloxacillin
dc.subjectcotrimoxazole
dc.subjectheparin
dc.subjectinsulin
dc.subjectlevofloxacin
dc.subjectmeropenem
dc.subjectminocycline
dc.subjectvancomycin
dc.subjectwarfarin
dc.subjectaged
dc.subjectArticle
dc.subjectbacteremia
dc.subjectcase report
dc.subjectcomorbidity
dc.subjectdeep vein thrombosis
dc.subjectdyslipidemia
dc.subjectElizabethkingia meningoseptica
dc.subjectend stage renal disease
dc.subjectendogenous endophthalmitis
dc.subjectendogenous endophthalmitis
dc.subjectendophthalmitis
dc.subjectfatty acid desaturation
dc.subjectfemale
dc.subjectGlasgow coma scale
dc.subjecthemodialysis
dc.subjecthospitalization
dc.subjecthuman
dc.subjecthypertension
dc.subjectischemic heart disease
dc.subjectmethicillin susceptible Staphylococcus aureus
dc.subjectneuroimaging
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectosteoarthritis
dc.subjectpriority journal
dc.subjectsepsis
dc.subjectseptic shock
dc.subjectspondylosis
dc.subjectvisual acuity
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1186/2047-2994-3-35
dc.description.sourcetitleAntimicrobial Resistance and Infection Control
dc.description.volume3
dc.description.issue1
dc.description.page35
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_2047-2994-3-35.pdf239.73 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons